A major way we are seeing innovation in digital health is in how care can be delivered. Tiposi has downsized traditional neuroimaging technology with its prototype MWI Brain Scanner, making both micro and major waves at CES 2026. As a CES Innovation Awards® 2026 honoree in Artificial Intelligence, the MWI Brain Scanner drew international attention, with long lines forming as media, clinicians and attendees lined up for a chance to try the breakthrough neuroimaging platform

Designed for emergency responders, neurologists and rural healthcare settings, the MWI Brain Scanner weighs just 8 kg and is a portable neuroimaging platform that uses microwave imaging and AI to detect strokes, while also producing diagnostic-grade brain images in under two minutes — without ionizing radiation.

Hans Masli, VP of Business Development & Partnerships at Tiposi, shared how CES expedited the company’s growth.

“Being recognized as a CES Innovation Awards 2026 honoree positioned Tiposi as a rising leader in next-generation neuroimaging — instilling customer trust and investor confidence. By participating in the Innovation Showcase and as an exhibitor, CES was a powerful catalyst for our partnership development, expanding our engagement with hospitals and health systems, medical device distributors, government health agencies and leading AI research collaborators worldwide. Tiposi also takes advantage of the standards CTA sets to best align with evolving practices in AI, medical devices and emerging health technology.”

Following its success at the show, we can anticipate a busy year ahead for Tiposi. The company will continue advancing the MWI Brain Health Platform, including AI diagnostic algorithms for other neurodegenerative diseases such as Alzheimer’s, brain trauma, early diagnosis of cognitive decline, tumors and more.

Become an early player in market-shaping decisions by engaging with CTA’s ANSI-Accredited Standards Program. CTA’s standards create a blueprint that drives trust and consumer adoption.

Imagine a world where a patient can recover in the comfort of their own home. Xandar Kardian has adapted its FDA-cleared contactless monitoring technology — which has already helped thousands of patients — into new plug-and-play consumer products.

Xandar Kardian showed up in a big way at CES 2026, unveiling consumer products designed for seamless integration into home monitoring. The device uses ultra-wideband radar to monitor health and presence without the need for wearables or cameras, measuring breathing, heart rate and movement even through blankets or walls. It is designed for several applications, from healthcare in the home and hospitals to assisted living facilities and even building maintenance for environments such as security, hospitality and commercial real estate.

The company’s CEO, Sam Yang, joined a session panel with other healthcare leaders as part of the CES 2026 digital health conference track, exploring how connected devices, remote monitoring and digital tools are making the home the hub of health and healing.

Leaders from the Centers of Medicare & Medicaid Services, including Administrator Dr. Mehmet Oz and FDA Commissioner Dr. Marty Makary, spent time on the CES digital health show floor engaging with technologies shaping the future of care, like Xandar Kardian — sparking conversations about real-world systems change.

Oracle Health and Life Sciences is committed to enabling intelligent connectivity and collaboration, helping clinicians spend less time searching for data and more time with their patients and building a health ecosystem where technology can support better care for all.

The recently launched Oracle Health EHR leverages AI to help physicians and nurses navigate, document and review patient information. A major topic of discussion at CES 2026, the platform is now being used in several ambulatory clinics across the U.S., delivering intelligent, actionable insights at the point of care.

By simplifying navigation with voice commands to find needed information, such as patient lab results and current medications, the new Oracle Health EHR is empowering clinicians with personalized, streamlined workflows — cutting administrative busywork. Looking ahead, Oracle plans to expand the system, including into acute care settings, and add more AI agents that will act as smart assistants for physicians and nurses.

Oracle’s Senior Director of Healthcare Policy and Government Affairs, Aliza Silver, shared how CES and the company’s CTA membership continue to propel them forward.

“The unique CES audience provides us with a powerful opportunity to share with the world how Oracle’s technology positively impacts healthcare providers and those seeking care. As a new member, we’ve already benefited from the educational and networking opportunities CTA has opened for us.”

CTA continues to power the digital health industry year-round through standards leadership, such as the new iCGM guidelines, driving U.S. health AI policy and advocating across forums from Senate testimony to HHS and CMS roundtables. Our members help make it all possible — learn more today.